BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Israeli M, Finkel Y, Yahalom-Ronen Y, Paran N, Chitlaru T, Israeli O, Cohen-Gihon I, Aftalion M, Falach R, Rotem S, Elia U, Nemet I, Kliker L, Mandelboim M, Beth-Din A, Israely T, Cohen O, Stern-Ginossar N, Bercovich-Kinori A. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2. Nat Commun 2022;13:2237. [PMID: 35469023 DOI: 10.1038/s41467-022-29896-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cunha JB, Leix K, Sherman EJ, Mirabelli C, Kennedy AA, Lauring AS, Tai AW, Wobus CE, Emmer BT. Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection. bioRxiv 2023:2023. [PMID: 36909579 DOI: 10.1101/2023.02.28.530557] [Reference Citation Analysis]
2 Tang WF, Tran Anh T, Wang LY, Horng JT. SARS-CoV-2 pandemics: an update of CRISPR in diagnosis and host-virus interaction studies. Biomed J 2023:S2319-4170(23)00011-2. [PMID: 36849044 DOI: 10.1016/j.bj.2023.02.007] [Reference Citation Analysis]
3 Pinto SM, Subbannayya Y, Kim H, Hagen L, Górna MW, Nieminen AI, Bjørås M, Espevik T, Kainov D, Kandasamy RK. Multi-OMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells. iScience 2023;26:105895. [PMID: 36590899 DOI: 10.1016/j.isci.2022.105895] [Reference Citation Analysis]
4 Zhou Q, Chen Y, Wang R, Jia F, He F, Yuan F. Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment. Genes Dis 2022. [PMID: 36591005 DOI: 10.1016/j.gendis.2022.11.016] [Reference Citation Analysis]
5 Zhu X, Trimarco JD, Williams CA, Barrera A, Reddy TE, Heaton NS. ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection. Cell Rep 2022;41:111540. [PMID: 36243002 DOI: 10.1016/j.celrep.2022.111540] [Reference Citation Analysis]
6 Amahong K, Zhang W, Zhou Y, Zhang S, Yin J, Li F, Xu H, Yan T, Yue Z, Liu Y, Hou T, Qiu Y, Tao L, Han L, Zhu F. CovInter: interaction data between coronavirus RNAs and host proteins. Nucleic Acids Res 2023;51:D546-56. [PMID: 36200814 DOI: 10.1093/nar/gkac834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kearns FL, Sandoval DR, Casalino L, Clausen TM, Rosenfeld MA, Spliid CB, Amaro RE, Esko JD. Spike-heparan sulfate interactions in SARS-CoV-2 infection. Curr Opin Struct Biol 2022;76:102439. [PMID: 35926454 DOI: 10.1016/j.sbi.2022.102439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
8 Strine MS, Cai WL, Wei J, Alfajaro MM, Filler RB, Biering SB, Sarnik S, Patil A, Cervantes KS, Collings CK, Deweirdt PC, Hanna RE, Schofield K, Hulme C, Konermann S, Doench JG, Hsu PD, Kadoch C, Yan Q, Wilen CB. Kinase-independent activity of DYRK1A promotes viral entry of highly pathogenic human coronaviruses.. [DOI: 10.1101/2022.09.13.507833] [Reference Citation Analysis]
9 Pinto SM, Subbannayya Y, Kim H, Hagen L, Górna MW, Nieminen AI, Bjørås M, Espevik T, Kainov D, Kandasamy RK. MultiOMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells.. [DOI: 10.1101/2022.09.06.506768] [Reference Citation Analysis]
10 Badia R, Garcia-vidal E, Ballana E. Viral-Host Dependency Factors as Therapeutic Targets to Overcome Antiviral Drug-Resistance: A Focus on Innate Immune Modulation. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.935933] [Reference Citation Analysis]